Bluejay Diagnostics (BJDX) Inventory Average (2022 - 2025)
Bluejay Diagnostics (BJDX) reported Inventory Average of $600.0 for Q3 2025, down 99.44% sequentially from $107827.0 in Q4 2024.
Bluejay Diagnostics (BJDX) Inventory Average (2022 - 2025) Analysis & Trends
Bluejay Diagnostics (BJDX) has 3 years of Inventory Average data on file, last reported at $600.0 in Q3 2025.
- For the quarter ending Q3 2025, Inventory Average changed N/A year-over-year to $600.0; the trailing twelve-month figure through Sep 2025 stood at $600.0 (changed N/A YoY), and the FY2024 full-year result was $290452.5, down 53.16% from the prior year.
- Inventory Average retreated to $600.0 in Q3 2025, from $107827.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $782212.0 in Q2 2022 to a low of $600.0 in Q3 2025.
- A 3-year average of $354306.5 and a median of $317207.0 in 2022 frame the typical range for Inventory Average.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 661.35 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.49 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.29 Bn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 600.00 |
| Dec 31, 2024 | 107,827.00 |
| Jun 30, 2022 | 782,212.00 |
| Mar 31, 2022 | 526,587.00 |